Dr. Agarwal's Health Care (AGARWALEYE.NS) Earnings Analysis
Dr. Agarwal's Health Care (AGARWALEYE.NS) next reports earnings on 2026-08-18, consensus EPS 1.15 INR. Last quarter (2026-05-21) it beat with EPS 1.2 INR vs 1.07 INR est (+12.1%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E 113.78.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AGARWALEYE.NS next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | 1.15 INR |
| Revenue estimate | 5.93B |
AGARWALEYE.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-21 | 1.2 INR | 1.07 INR | +12.1% | Beat |
| 2025-10-30 | 0.93 INR | 0.9 INR | +3.3% | Beat |
| 2025-05-28 | 1.11 INR | 1.5 INR | -26% | Miss |
| 2025-02-14 | 0.499 INR | n/a | n/a | n/a |
| 2024-12-31 | 0.726 INR | n/a | n/a | n/a |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
AGARWALEYE.NS valuation and analyst view
| Trailing P/E | 113.78 |
|---|---|
| Trailing EPS | 4.193 INR |
| Price / book | 7.51 |
| Dividend yield | 0.00% |
| Market cap | 152.17B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Dr. Agarwal's Health Care (AGARWALEYE.NS)'s next earnings date?
Dr. Agarwal's Health Care is next scheduled to report on 2026-08-18, with a consensus EPS estimate of 1.15 INR and revenue estimate of 5.93B.
Did AGARWALEYE.NS beat earnings last quarter?
In its 2026-05-21 report, AGARWALEYE.NS posted EPS of 1.2 INR versus a 1.07 INR estimate — a beat of 12.1%.
What is AGARWALEYE.NS's earnings track record?
Over the last 3 reported quarters with consensus data, AGARWALEYE.NS beat estimates 2 times (67%).
What is AGARWALEYE.NS's current P/E ratio and EPS?
AGARWALEYE.NS trades at a trailing P/E of 113.78 on trailing EPS of 4.192583732057416 INR.
What do analysts rate AGARWALEYE.NS?
AGARWALEYE.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.